HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr

Virology

Volumn 245, Issue 2, 1998, Pages 323-330

  Gragerov, Alexander ^a   Kino, Tomoshige ^b   Ilyina Gragerova, Galina ^a   Chrousos, George P ^b   Pavlakis, George N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEQUENCE HOMOLOGY; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032486250     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9138     Document Type: Article

References (49)

1. Balliet J. W., Kolson D. L., Eiger G., Kim F. M., McGann K. A., Srinivasan A., Collman R. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: Mutational analysis of a primary HIV-1 isolate. Virology. 200:1994;623-631.
2. Bartz S. R., Rogel M. E., Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:1996;2324-2331.
3. Biggins S., Ivanovska I., Rose M. D. Yeast ubiquitin-like genes are involved in duplication of the microtubule organizing center. J. Cell Biol. 133:1996;1331-1346.
4. Bouhamdan M., Benichou S., Rey F., Navarro J. M., Agostini I., Spire B., Camonis J., Slupphaug G., Vigne R., Benarous R., Sire J. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:1996;697-704.
5. Cohen E. A., Terwilliger E. F., Jalinoos Y., Proulx J., Sodroski J. G., Haseltine W. A. Identification of HIV-1 vpr product and function. J. Acquired Immune Defic. Syndr. 3:1990;11.
6. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N. R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:1995;7909-7916.
7. Elledge S. J. Cell cycle checkpoints: Preventing an identity crisis. Science. 274:1996;1664-1672.
8. Felber B. K., Hadzopoulou-Cladaras M., Cladaras C., Copeland T., Pavlakis G. N. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA. 86:1989;1495-1499.
9. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
10. Finley R. L., Brent R. Interaction mating reveals binary and ternary connections betweenDrosophila. Proc. Natl. Acad. Sci. USA. 91:1994;12980-12984.
11. Finley R. L., Brent R. Interaction trap cloning with yeast. DNA Cloning, Expression Systems: A Practical Approach. 1995;Oxford Univ. Press, Oxford. p. 169-203.
12. Gibbs J. S., Lackner A. A., Lang S. M., Simon M. A., Sehgal P. K., Daniel M. D., Desrosiers R. C. Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69:1995;2378-2383.
13. Guzder S. N., Bailly V., Sung P., Prakash L., Prakash S. Yeast DNA repair protein RAD23 promotes complex formation between transcription factor TFIIH and DNA damage recognition factor RAD14. J. Biol. Chem. 270:1995;8385-8388.
14. Gyuris J., Golemis E., Chertkov H., Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell. 75:1993;791-803.
15. Hattori N., Michaels F., Fargnoli K., Marcon L., Gallo R. C., Franchini G. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA. 87:1990;8080-8084.
16. He J., Choe S., Walker R., Di Marzio P., Morgan D. O., Landau N. R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:1995;6705-6711.
17. Heery D. M., Kalkhoven E., Hoare S., Parker M. G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
18. Heinzinger N. K., Bukrinsky M. I., Haggerty S. A., Ragland A. M., Kewalramani V., Lee M. A., Gendelman H. E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
19. Jowett J. B., Planelles V., Poon B., Shah N. P., Chen M. L., Chen I. S. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69:1995;6304-6313.
20. Karl M., Lamberts S. W., Koper J. W., Katz D. A., Huizenga N. E., Kino T., Haddad B. R., Hughes M. R., Chrousos G. P. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc. Assoc. Am. Physicians. 108:1996;296-307.
21. Kino, T. Kopp, J. B. Stauber, R. H. Gragerov, A. Chen, Z. J. Alexander, K. Pavlakis, G. N. Chrousos, G. 1998, The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor: Potential implications in the pathogenesis and clinical presentation of AIDS.
22. Lang S. M., Weeger M., Stahl-Hennig C., Coulibaly C., Hunsmann G., Muller J., Muller-Hermelink H., Fuchs D., Wachter H., Daniel M. M. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:1993;902-912.
23. Lavallee C., Yao X. J., Ladha A., Gottlinger H., Haseltine W. A., Cohen E. A. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J. Virol. 68:1994;1926-1934.
24. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell. 72:1993;541-550.
25. Levy D. N., Refaeli Y., MacGregor R. R., Weiner D. B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 91:1994;10873-10877.
26. Madura S., Prakash S. Transcript levels of the Saccharomyces cerevisiae DNA repair gene RAD23 increase in response to UV light and in meiosis but remain constant in the mitotic cell cycle. Nucleic Acids Res. 18:1990;4737-4742.
27. Masutani C., Sugasawa K., Yanagisawa J., Sonoyama T., Ui M., Enomoto T., Takio K., Tanaka K., van der Spek P. J., Bootsma D. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J. 13:1994;1831-1843.
28. Miller R. H., Sarver N. HIV accessory proteins as therapeutic targets. Nature Med. 3:1997;389-394.
29. Mueller J. P., Smerdon M. J. Rad23 is required for transcription-coupled repair and efficient overrall repair inSaccharomyces cerevisiae. Mol. Cell. Biol. 16:1996;2361-2368.
30. Pavlakis G. N. The molecular biology of HIV-1. DeVita V. T., Hellman S., Rosenberg S. A. AIDS: Etiology, Diagnosis, Treatment and Prevention. 1996;45-74 Lippincott-Raven, Philadelphia.
31. Paxton W., Connor R. I., Landau N. R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67:1993;7229-7237.
32. Poon B., Jowett J. B., Stewart S. A., Armstrong R. W., Rishton G. M., Chen I. S. Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. J. Virol. 71:1997;3961-3971.
33. Rafaeli Y., Levy D. N., Weiner D. B. The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA. 92:1995;3621-3625.
34. Re F., Braaten D., Franke E. K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:1995;6859-6864.
35. Rogel M. E., Wu L. I., Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:1995;882-888.
36. Selig L., Benichou S., Rogel M. E., Wu L. I., Vodicka M. A., Sire J., Benarous R., Emerman M. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 71:1997;4842-4846.
37. Smith C. L., Onate S. A., Tsai M. J., O'Malley B. W. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA. 93:1996;8884-8888.
38. Stivahtis G. L., Soares M. A., Vodicka M. A., Hahn B. H., Emerman M. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J. Virol. 71:1997;4331-4338.
39. Sugasawa K., Masutani C., Uchida A., Maekawa T., van der Spek P. J., Bootsma D., Hoeijmakers J. H. J., Hanaoka F. HHR23B, a human Rad 23 homolog, stimulates XPC protein in nucleotide excision repair in vitro. Mol. Cell. Biol. 16:1996;4852-4861.
40. Torchia J., Rose D. W., Inostroza J., Kamei Y., Westin S., Glass C. K., Rosenfeld M. G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684.
41. Tristem M., Marshall C., Karpas A., Hill F. Evolution of the primate lentiviruses: Evidence from vpx and vpr. EMBO J. 11:1992;3405-3412.
42. Trono D. HIV accessory proteins: Leading roles for the supporting cast. Cell. 82:1995;189-192.
43. van der Spek P. J., Eker A., Rademakers S., Visser C., Sugasawa K., Masutani C., Hanaoka F., Bootsma D., Hoeijmakers J. H. XPC and human homologs of RAD23: Intracellular localization and relationship to other nucleotide excision repair complexes. Nucleic Acids Res. 24:1996a;2551-2559.
44. van der Spek P. J., Visser C. E., Hanaoka F., Smit B., Hagemeuer A., Bootsma D., Hoeumakers J. H. J. Cloning, comparative mapping, and RNA expression of the mouse homologues of theSaccharomyces cerevisiae. Genomics. 31:1996b;20-27.
45. Wang J. J., Lu Y., Ratner L. Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy. J. Gen. Virol. 75:1994;2607-2614.
46. Wang Z., Wei S., Reed S. H., Wu X., Svejstrup J. Q., Feaver W. J., Kornberg R. D., Friedberg E. C. The RAD7, RAD16, and RAD23 genes of Saccharomyces cerevisiae: Requirement for transcription-independent nucleotide excision repair in vitro and interactions between the gene products. Mol. Cell. Biol. 17:1997;635-643.
47. Watkins J. F., Sung P., Prakash L., Prakash S. TheSaccharomyces cerevisiae. Mol. Cell. Biol. 13:1993;7757-7765.
48. Withers-Ward E. S., Jowett J. B. M., Stewart S. A., Xie Y.-M., Garfinkel A., Shibagaki Y., Chow S. A., Shah N., Hanaoka F., Sawitz D. G., Armstrong R. W., Souza L. M., Chen I. S. Y. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J. Virol. 71:1997;9732-9742.
49. Zhao L. J., Mukherjee S., Narayan O. Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. J. Biol. Chem. 269:1994;15577-15582.